MYWOT
N/A
0%
N/A
0%
MALICIOUS CONTENT INDICATORS
Urotoday.com most likely does not offer any malicious content.
Secure connection support
HTTPS
ADULT CONTENT INDICATORS
Urotoday.com most likely does not offer any adult content.
Audience
-
Bounce rate
-
Time on site
03:20
AVG
-
Gender
Popular pages
- UroToday - The Global Online Community of Urologists
- ASCO GU 2022: Phase 1 Results of the ODM-208 First-in-Human Phase 1–2 Trial in Patients With
- The Latest Research on Bladder Cancer - UroToday
- SUO 2020: Final Results of the OLYMPUS Study - Durability of Response to Chemoablative Treatment of
- AUA 2023: EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and
- Treatment and Survival Differences in Patients With Urothelial Vs. Nonurothelial Bladder & Upper